These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25268903)

  • 1. Retention and risk factors for attrition in a large public health ART program in Myanmar: a retrospective cohort analysis.
    Thida A; Tun ST; Zaw SK; Lover AA; Cavailler P; Chunn J; Aye MM; Par P; Naing KW; Zan KN; Shwe M; Kyaw TT; Waing ZH; Clevenbergh P
    PLoS One; 2014; 9(9):e108615. PubMed ID: 25268903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attrition among HIV positive children enrolled under integrated HIV care programme in Myanmar: 12 years cohort analysis.
    Minn AC; Kyaw NTT; Aung TK; Mon OM; Htun T; Oo MM; Moe J; Mon AA; Satyanarayana S; Oo HN
    Glob Health Action; 2018; 11(1):1510593. PubMed ID: 30191749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
    J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are death and loss to follow-up still high in people living with HIV on ART after national scale-up and earlier treatment initiation? A large cohort study in government hospital-based setting, Myanmar: 2013-2016.
    Aung ZZ; Oo MM; Tripathy JP; Kyaw NTT; Hone S; Oo HN; Majumdar SS
    PLoS One; 2018; 13(9):e0204550. PubMed ID: 30252904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcomes from the largest antiretroviral treatment program in Myanmar (Burma): a cohort analysis of retention after scale-up.
    Sabapathy K; Ford N; Chan KN; Kyaw MK; Elema R; Smithuis F; Floyd S
    J Acquir Immune Defic Syndr; 2012 Jun; 60(2):e53-62. PubMed ID: 22334069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with long-term antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective study.
    Okoboi S; Ssali L; Yansaneh AI; Bakanda C; Birungi J; Nantume S; Okullu JL; Sharp AR; Moore DM; Kalibala S
    J Int AIDS Soc; 2016; 19(5 Suppl 4):20841. PubMed ID: 27443271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High attrition among HIV-infected patients with advanced disease treated in an intermediary referral center in Maputo, Mozambique.
    Molfino L; Kumar AM; Isaakidis P; Van den Bergh R; Khogali M; Hinderaker SG; Magaia A; Lobo S; Edwards CG; Walter J
    Glob Health Action; 2014; 7():23758. PubMed ID: 24717189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in Zimbabwe.
    Makurumidze R; Buyze J; Decroo T; Lynen L; de Rooij M; Mataranyika T; Sithole N; Takarinda KC; Apollo T; Hakim J; Van Damme W; Rusakaniko S
    PLoS One; 2020; 15(10):e0240865. PubMed ID: 33075094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and predictors of attrition from antiretroviral care among adults in a rural HIV clinic in Coastal Kenya: a retrospective cohort study.
    Hassan AS; Mwaringa SM; Ndirangu KK; Sanders EJ; de Wit TF; Berkley JA
    BMC Public Health; 2015 May; 15():478. PubMed ID: 25957077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with death and loss to follow-up in children on antiretroviral care in Mingalardon Specialist Hospital, Myanmar, 2006-2016.
    Kaung Nyunt KK; Han WW; Satyanarayana S; Isaakidis P; Hone S; Khaing AA; Nguyen Binh H; Oo HN
    PLoS One; 2018; 13(4):e0195435. PubMed ID: 29621302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alarming attrition rates among HIV-infected individuals in pre-antiretroviral therapy care in Myanmar, 2011-2014.
    Oo MM; Gupta V; Aung TK; Kyaw NT; Oo HN; Kumar AM
    Glob Health Action; 2016; 9():31280. PubMed ID: 27562473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of second-line antiretroviral treatment in an adult and adolescent cohort in Myanmar.
    Kyaw NTT; Kumar AMV; Oo MM; Oo HN; Kyaw KWY; Thiha S; Aung TK; Win T; Mon YY; Harries AD
    Glob Health Action; 2017; 10(1):1290916. PubMed ID: 28594295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007-2010.
    Mutasa-Apollo T; Shiraishi RW; Takarinda KC; Dzangare J; Mugurungi O; Murungu J; Abdul-Quader A; Woodfill CJ
    PLoS One; 2014; 9(1):e86305. PubMed ID: 24489714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body and mind: retention in antiretroviral treatment care is improved by mental health training of care providers in Ethiopia.
    Berheto TM; Hinderaker SG; Senkoro M; Tweya H; Deressa T; Getaneh Y; Gezahegn G
    BMC Public Health; 2018 Jul; 18(1):896. PubMed ID: 30029598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention in Care of Adult HIV Patients Initiating Antiretroviral Therapy in Tigray, Ethiopia: A Prospective Observational Cohort Study.
    Bucciardini R; Fragola V; Abegaz T; Lucattini S; Halifom A; Tadesse E; Berhe M; Pugliese K; Binelli A; De Castro P; Terlizzi R; Fucili L; Di Gregorio M; Mirra M; Olivieri E; Teklu T; Zegeye T; Haile A; Vella S; Abraham L; Godefay H;
    PLoS One; 2015; 10(9):e0136117. PubMed ID: 26340271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmatic outcomes and impact of rapid public sector antiretroviral therapy expansion in adults prior to introduction of the WHO treat-all approach in rural Eswatini.
    Kerschberger B; Schomaker M; Ciglenecki I; Pasipamire L; Mabhena E; Telnov A; Rusch B; Lukhele N; Teck R; Boulle A
    Trop Med Int Health; 2019 Jun; 24(6):701-714. PubMed ID: 30938037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attrition during pre-ART and ART time periods among adolescents enrolled in Integrated HIV Care Programme in Myanmar, 2005-2017.
    Htun T; Kyaw KWY; Aung TK; Moe J; Mon AA; Tun CL; Mon O; Satyanarayana S; Oo HN
    Epidemiol Infect; 2019 Jan; 147():e206. PubMed ID: 31364536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of adherence support and outreach services with total attrition, loss to follow-up, and death among ART patients in sub-Saharan Africa.
    Lamb MR; El-Sadr WM; Geng E; Nash D
    PLoS One; 2012; 7(6):e38443. PubMed ID: 22685569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.